A nanomedicine engineering and development company focused on advanced drug delivery systems and nanoformulation technologies.
NanoCore Pharma is an Argentina-based technology-driven company dedicated to the engineering, development, and Technology Transfer of advanced nanomedicine systems.
We specialize in the design, optimization, and translational development of nanoformulated therapeutics, integrating scientific rigor with engineering precision.
Our hybrid model combines strategic nanoformulation and drug delivery services for complex pharmaceutical products with targeted development initiatives.
We collaborate with industry and research institutions globally to accelerate the translation of advanced nanomedicine technologies into viable therapeutic solutions.
The NanoCore Pharma leadership and advisory team has contributed to highly cited publications in leading international journals and to patented technologies in nanomedicine and advanced drug delivery systems.
NanoCore supports pharmaceutical partners in transforming complex nanoformulation concepts into robust development programs and scalable technologies.
We enable pharmaceutical innovation through engineering precision.
Pharmaceutical development programs may benefit from NanoCore’s involvement when specialized nanoengineering expertise is required to advance complex drug delivery systems.
NanoCore becomes particularly valuable when internal R&D teams face technically complex nanoformulation challenges that require specialized engineering expertise to move from concept to viable pharmaceutical development.
NanoCore integrates seamlessly with existing pharmaceutical R&D teams, providing focused technical depth while supporting industrial feasibility and development execution.
Founder & Scientific Director
Nanomedicine researcher and pharmaceutical formulation specialist with extensive experience in liposomal drug delivery, nanoengineering, and complex injectable systems development. Co-inventor of patented nanomedicine technologies and author of peer-reviewed scientific publications in advanced drug delivery systems.
If your team is exploring complex drug delivery challenges or advanced nanoformulation strategies, NanoCore is always open to informal technical discussions.
We regularly collaborate with pharmaceutical R&D groups seeking specialized engineering support for demanding development programs.
Many collaborations begin with a short technical exchange to assess feasibility and potential development pathways.
All inquiries are treated with strict professional confidentiality.
NanoCore collaborates with pharmaceutical partners worldwide.
Scientific & Clinical Development Advisor
Scientist and clinical development leader with more than 15 years of international experience in drug discovery, pharmaceutical development, and early-stage clinical research. Author of peer-reviewed publications in high-impact journals including PNAS, JACS, and JBC.
Nanoprocess Engineering Advisor
Principal Investigator at CONICET specializing in micro- and millifluidic processes for nanoparticle production. Author of peer-reviewed publications in leading journals such as ACS Nano, Nano Letters, and Langmuir.
Strategic Operations Advisor
Senior pharmaceutical executive with over 30 years of leadership experience in global pharma operations. Expertise includes large-scale production management, supply chain optimization, logistics, and CMO/CDMO supervision, supporting industrial and operational scalability.